3 biotech groups sue CMS over drug pricing rule
Three biotechnology trade groups filed a lawsuit Nov. 6 challenging CMS’ Global Benchmark for Efficient Drug Pricing Model, known as GLOBE, arguing the agency exceeded its statutory authority in finalizing the model. The Biotechnology Innovation Organization, Biocom and California Life Sciences filed the complaint in the U.S. District Court for the Northern District of California. […] The post 3 biotech groups sue CMS over drug pricing rule appeared first on Becker's Hospital Review |...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.